| Vimentin as a poor prognostic factor for triple-negative breast cancer N Yamashita, E Tokunaga, H Kitao, Y Hisamatsu, K Taketani, S Akiyoshi, ... Journal of cancer research and clinical oncology 139, 739-746, 2013 | 157 | 2013 |
| MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Y Yasumizu, H Rajabi, C Jin, T Hata, S Pitroda, MD Long, M Hagiwara, ... Nature communications 11 (1), 338, 2020 | 133 | 2020 |
| Epithelial paradox: clinical significance of coexpression of E-cadherin and vimentin with regard to invasion and metastasis of breast cancer N Yamashita, E Tokunaga, M Iimori, Y Inoue, K Tanaka, H Kitao, H Saeki, ... Clinical breast cancer 18 (5), e1003-e1009, 2018 | 96 | 2018 |
| Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer E Tokunaga, Y Nakashima, N Yamashita, Y Hisamatsu, S Okada, ... Breast cancer 21, 341-349, 2014 | 75 | 2014 |
| The Japanese breast cancer society clinical practice guidelines for systemic treatment of breast cancer, 2018 edition T Shimoi, SE Nagai, T Yoshinami, M Takahashi, H Arioka, M Ishihara, ... Breast Cancer 27, 322-331, 2020 | 66 | 2020 |
| Epigenetic inactivation of BRCA1 through promoter hypermethylation and its clinical importance in triple-negative breast cancer N Yamashita, E Tokunaga, H Kitao, M Hitchins, Y Inoue, K Tanaka, ... Clinical breast cancer 15 (6), 498-504, 2015 | 64 | 2015 |
| Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer Y Hisamatsu, E Tokunaga, N Yamashita, S Akiyoshi, S Okada, ... Annals of surgical oncology 19, 1145-1152, 2012 | 64 | 2012 |
| MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer N Yamashita, M Long, A Fushimi, M Yamamoto, T Hata, M Hagiwara, ... Journal for immunotherapy of cancer 9 (1), 2021 | 63 | 2021 |
| MUC1-C activates the BAF (mSWI/SNF) complex in prostate cancer stem cells M Hagiwara, Y Yasumizu, N Yamashita, H Rajabi, A Fushimi, MD Long, ... Cancer research 81 (4), 1111-1122, 2021 | 62 | 2021 |
| MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells M Hagiwara, A Fushimi, N Yamashita, A Bhattacharya, H Rajabi, ... Oncogene 40 (30), 4930-4940, 2021 | 57 | 2021 |
| MUC1-C activates the NuRD complex to drive dedifferentiation of triple-negative breast cancer cells T Hata, H Rajabi, H Takahashi, Y Yasumizu, W Li, C Jin, MD Long, Q Hu, ... Cancer research 79 (22), 5711-5722, 2019 | 56 | 2019 |
| Molecular mechanisms regulating the hormone sensitivity of breast cancer E Tokunaga, Y Hisamatsu, K Tanaka, N Yamashita, H Saeki, E Oki, ... Cancer science 105 (11), 1377-1383, 2014 | 52 | 2014 |
| MUC1-C drives stemness in progression of colitis to colorectal cancer W Li, N Zhang, C Jin, MD Long, H Rajabi, Y Yasumizu, A Fushimi, ... JCI insight 5 (12), 2020 | 49 | 2020 |
| Impact of expression of vimentin and Axl in breast cancer K Tanaka, E Tokunaga, Y Inoue, N Yamashita, H Saeki, S Okano, H Kitao, ... Clinical breast cancer 16 (6), 520-526. e2, 2016 | 49 | 2016 |
| High expression of the Notch ligand Jagged‐1 is associated with poor prognosis after surgery for colorectal cancer M Sugiyama, E Oki, Y Nakaji, S Tsutsumi, N Ono, R Nakanishi, ... Cancer science 107 (11), 1705-1716, 2016 | 49 | 2016 |
| Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer Y Hisamatsu, E Tokunaga, N Yamashita, S Akiyoshi, S Okada, ... Breast cancer 22, 520-528, 2015 | 48 | 2015 |
| Protein expression of programmed death 1 ligand 1 and HER2 in gastric carcinoma E Oki, S Okano, H Saeki, Y Umemoto, K Teraishi, Y Nakaji, K Ando, ... Oncology 93 (6), 387-394, 2017 | 45 | 2017 |
| Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer Y Nakaji, E Oki, R Nakanishi, K Ando, M Sugiyama, Y Nakashima, ... Journal of cancer research and clinical oncology 143, 151-160, 2017 | 45 | 2017 |
| Surgical strategies for esophageal cancer associated with head and neck cancer M Morita, H Saeki, S Ito, Y Kimura, N Yamashita, K Ando, Y Hiyoshi, ... Surgery today 44, 1603-1610, 2014 | 37 | 2014 |
| Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer E Tokunaga, Y Hisamatsu, K Taketani, N Yamashita, S Akiyoshi, S Okada, ... Cancer medicine 2 (6), 763-773, 2013 | 36 | 2013 |
